La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Istex)

Index « Keywords » - entrée « glutamate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
glucocorticoid negative feedback < glutamate < glutamate decarboxylase  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000274 (2012) Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France]A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease
000513 (2010) Carine Chassain [France] ; Guy Bielicki [France] ; Cécile Keller [France] ; Jean-Pierre Renou [France] ; Franck Durif [France]Metabolic changes detected in vivo by 1H MRS in the MPTP‐intoxicated mouse
000540 (2010) Adrien Quintana [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Pascal Salin [France] ; Marc Savasta [France] ; Véronique Sgambato-Faure [France]Forelimb dyskinesia mediated by high‐frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N‐methyl‐d‐aspartate receptors
000553 (2010) David Devos [France] ; L. Defebvre [France] ; R. Bordet [France]Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease
000724 (2009) N. Kickler [France, Suisse] ; E. Lacombe [France] ; C. Chassain [France] ; F. Durif [France] ; A. Krainik [France] ; R. Farion [France] ; P. Provent [France] ; C. Segebarth [France] ; C. Rémy [France] ; M. Savasta [France]Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo 1H MRS study
000907 (2007) Nils Kickler [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Jean-François Lebas [France] ; Laurent Lamalle [France] ; Franck Durif [France] ; Alexandre Krainik [France] ; Chantal Rémy [France] ; Christoph Segebarth [France] ; Pierre Pollak [France]Glutamate measurement in Parkinson's disease using MRS at 3 T field strength
000A30 (2006) Paolo Gubellini [France] ; Alexandre Eusebio [France] ; Abid Oueslati [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Pascal Salin [France]Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
000C33 (2004) S. Robelet [France] ; C. Melon [France] ; B. Guillet [France] ; P. Salin [France] ; L. Kerkerian-Le Goff [France]Chronic l‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
000E34 (2001) C. Gilles [France] ; S. Ertlé [France] ; J. P Macher [France]Les modèles pharmacologiques dans la recherche sur la maladie d’Alzheimer
000E93 (2001) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grandbois [Canada] ; Didier Pélaprat [France] ; Thérèse Di Paolo [Canada]Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
000F06 (2001) C. Marin [Espagne] ; A. Jiménez [Espagne] ; M. Bonastre [Espagne] ; M. Vila [France, États-Unis] ; Yves Agid [France] ; E. C. Hirsch [France] ; E. Tolosa [Espagne]LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa‐induced motor alterations in Parkinsonian rats
001142 (2000) C. Struys-Ponsar [Belgique] ; O. Guillard [France] ; Ph. Van Den Bosch De Aguilar [Belgique]Effects of Aluminum Exposure on Glutamate Metabolism: A Possible Explanation for Its Toxicity
001296 (1999) Françoise Esclaire [France] ; Glen Kisby ; Peter Spencer ; John Milne ; Mathieu Lesort [France] ; Jacques Hugon [France]The Guam Cycad Toxin Methylazoxymethanol Damages Neuronal DNA and Modulates Tau mRNA Expression and Excitotoxicity

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i -k "glutamate" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i  \
                -Sk "glutamate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    glutamate
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024